StockNews.AI
ELAN
Benzinga
12 hrs

Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around'

1. Jim Cramer recommended buying Elanco for its positive turnaround. 2. Barclays initiated coverage with an Overweight rating and $30 price target. 3. Elanco shares have seen a recent 1.8% decline. 4. Market sentiment supports potential future growth for Elanco. 5. Analysts express confidence in Elanco's strategic direction.

4m saved
Insight
Article

FAQ

Why Bullish?

Cramer’s endorsement and Barclays’ rating enhance investor confidence, despite current share decline.

How important is it?

Analyst upgrades and Cramer's positive remarks significantly impact investors' purchasing decisions.

Why Short Term?

Positive analyst coverage can lead to immediate trades, boosting share price in the near term.

Related Companies

Related News